Ignite Creation Date:
2025-12-25 @ 4:41 AM
Ignite Modification Date:
2026-02-06 @ 7:07 AM
Study NCT ID:
NCT07303218
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-24
First Post:
2025-12-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The HER Project: HRD in EGFR-mutated NSCLC
Sponsor:
IRCCS San Raffaele
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | EGFR | View |
| None | Non small cell lung cancer | View |
| None | NSCLC | View |
| None | Homologous Recombination Deficiency | View |
| None | HRD | View |
| None | PARP Inhibitors | View |
| None | cell lines | View |
| None | organoids | View |
| None | Osimertinib | View |
| None | Olaparib | View |
| None | Genomic Scarring Score | View |
| None | TP53 | View |